Ep. 138: “Cell-Based Therapies in Late-Stage Clinical Trial” Featuring Dr. Robert Mays

The Stem Cell Podcast - Ein Podcast von The Stem Cell Podcast - Dienstags

Guest: Dr. Robert Mays is the Co-founder and Vice President of Regenerative Medicine and Head of Neuroscience Programs at Athersys Inc. He focuses on Athersys' proprietary stem cell product, MultiStem®, and its applications in regenerative medicine and drug discovery, with a specific focus on injuries and diseases affecting the central nervous system. Featured Resource: Apply to become a co-host on the Stem Cell Podcast! Cytokines Resources and Links New Drug Developed to Treat Heart Attack Damage - Using iPSC-derived cardiomyocytes, scientists have developed a new drug that minimizes cardiomyocyte death following a heart attack. Enhancing iPSC Immune Compatibility - Researchers used CRISPR to make immunocompatible donor iPSCs that could increase iPSC-based regenerative medicine applications. Kidney Organoids Created from Urine - Researchers have generated kidney tubular epithelial organoids from both kidney tissue and urine cells, which can be used for personalized disease modeling. Modeling Developmental Disorder with Brain Organoids - Cerebral organoids were used to model the developmental disorder neuronal heterotopia, providing insight into the mechanisms causing impaired neuronal migration. Cancer-Specific Inhibitor Identified - Researchers have identified a cancer-specific inhibitor that targets the metabolic needs of cancer cells.   Photo Reference: Courtesy of Dr. Robert Mays #footable_5807 { font-family: inherit; font-size: 14px; } #footable_parent_5807 thead { display: none; } #footable_parent_5807 a.nt_edit_link { display: none; } #footable_parent_5807 td { border-color: #fff; } #footable_parent_5807 img { margin-top: 0px; } .semantic_ui .ui.table { border: 0px solid !important; } .semantic_ui .ui.table td { padding: 0em; } #footable_5808 { font-family: inherit; font-size: 14px; } thead { display: none; } #footable_parent_5808 a.nt_edit_link { display: none; } #footable_parent_5808 td { border-color: #fff; } #footable_parent_5808 img { margin-top: 0px; } .semantic_ui .ui.table { border: 0px solid !important; } .semantic_ui .ui.table td { padding: 0em; } #footable_5807 { font-family: inherit; font-size: 14px; } #footable_parent_5807 thead { display: none; } #footable_parent_5807 a.nt_edit_link { display: none; } #footable_parent_5807 td { border-color: #fff; } #footable_parent_5807 img { margin-top: 0px; } .semantic_ui .ui.table { border: 0px solid !important; } .semantic_ui .ui.table td { padding: 0em; } #footable_5808 { font-family: inherit; font-size: 14px;

Visit the podcast's native language site